Pages that link to "Q35280041"
Jump to navigation
Jump to search
The following pages link to Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity. (Q35280041):
Displaying 22 items.
- Engineered HSV vector achieves safe long-term transgene expression in the central nervous system (Q33685490) (← links)
- Construction of Various γ34.5 Deleted Fluorescent-Expressing Oncolytic herpes Simplex type 1 (oHSV) for Generation and Isolation of HSV-Based Vectors (Q33766379) (← links)
- Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus (Q38735164) (← links)
- Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread. (Q38791776) (← links)
- Gene transfer to the outflow tract. (Q38821882) (← links)
- Viral Vector Biosafety in Laboratory Animal Research (Q39149034) (← links)
- Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes (Q40124870) (← links)
- Synergistic effects of deleting multiple nonessential elements in nonreplicative HSV-1 BAC genomic vectors play a critical role in their viability. (Q40182069) (← links)
- Morphological changes in different populations of bladder afferent neurons detected by herpes simplex virus (HSV) vectors with cell-type-specific promoters in mice with spinal cord injury (Q41931257) (← links)
- Moving toward a gene therapy for Huntington's disease. (Q45291688) (← links)
- Sustained FXN expression in dorsal root ganglia from a nonreplicative genomic HSV-1 vector (Q45873314) (← links)
- And Then There Was Light: Perspectives of Optogenetics for Deep Brain Stimulation and Neuromodulation (Q47300209) (← links)
- New Tools for Epilepsy Therapy. (Q54988377) (← links)
- Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression (Q57169063) (← links)
- Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System (Q58779571) (← links)
- A Novel Oncolytic Herpes Simplex Virus Design based on the Common Overexpression of microRNA-21 in Tumors (Q59350354) (← links)
- On the development of optical peripheral nerve interfaces (Q64082902) (← links)
- Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9 (Q83225630) (← links)
- Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies (Q89640641) (← links)
- Gene Therapy Tools for Brain Diseases (Q91938470) (← links)
- Protocol Optimization for the Production of the Non-Cytotoxic JΔNI5 HSV Vector Deficient in Expression of Immediately Early Genes (Q92002965) (← links)
- A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy (Q92155680) (← links)